Status:
COMPLETED
Urinary Biomarkers Characteristic to Interstitial Cystitis
Lead Sponsor:
Corewell Health East
Conditions:
Interstitial Cystitis
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective study of urine samples stored in the Beaumont BioBank for future research. The urine samples will be drawn from the urine back with patients previously diagnosed with severe in...
Detailed Description
Extensive research has been done to understand the multifactorial etiology as well as to help diagnose IC. Infectious, autoimmune and anatomic causes have been looked at with few usable results. Infla...
Eligibility Criteria
Inclusion
- Patients who have previously been contacted and consented to place a sample within the biobank. We will select five representative patients from the severe IC diagnosis, mild IC diagnosis, and no IC diagnosis, and we will match these patients as best as possible within the limited biobank samples.
Exclusion
- None
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00971568
Start Date
September 1 2009
End Date
September 1 2011
Last Update
March 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Hospitals-Royal Oak
Royal Oak, Michigan, United States, 48073